Algorhythm Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Algorhythm Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $23.49M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $29.20M | Apr 15, 2025 |
| FY2023 | Mar 31, 2023 | $39.30M | Jul 14, 2023 |
| FY2023 | Mar 31, 2022 | $47.50M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $45.80M | Jul 14, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $23.49M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $29.20M | Apr 15, 2025 |
| FY2023 | Mar 31, 2023 | $39.30M | Jul 14, 2023 |
| FY2023 | Mar 31, 2022 | $47.51M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $45.80M | Jul 14, 2022 |
| FY2021 | Mar 31, 2020 | $38.50M | Jul 14, 2021 |
| FY2020 | Aug 31, 2019 | $1.60M | Feb 19, 2021 |
| FY2019 | Mar 31, 2019 | $889.0K | Jul 1, 2019 |
| FY2019 | Dec 31, 2018 | $19.45M | Jul 1, 2019 |
| FY2019 | Sep 30, 2018 | $24.31M | Jul 1, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | ($4.64M) | Jul 14, 2023 |
| FY2023 | Mar 31, 2022 | $230.5K | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $2.17M | Jul 14, 2022 |
| FY2021 | Mar 31, 2020 | ($2.86M) | Jul 14, 2021 |
| FY2019 | Mar 31, 2019 | ($841.0K) | Jul 1, 2019 |
| FY2019 | Dec 31, 2018 | $1.29M | Jul 1, 2019 |
| FY2019 | Sep 30, 2018 | $1.22M | Jul 1, 2019 |
| FY2019 | Jun 30, 2018 | ($1.03M) | Jul 1, 2019 |
| FY2019 | Mar 31, 2018 | ($1.26M) | Jul 1, 2019 |
| FY2019 | Dec 31, 2017 | $1.15M | Jul 1, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($13.93M) | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | ($6.14M) | Apr 15, 2025 |
| FY2023 | Mar 31, 2023 | ($3.70M) | Jul 14, 2023 |
| FY2023 | Mar 31, 2022 | $69.2K | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $1.43M | Jul 14, 2022 |
| FY2021 | Mar 31, 2020 | ($3.24M) | Jul 14, 2021 |
| FY2020 | Mar 31, 2019 | $1.05M | Feb 19, 2021 |
| FY2019 | Mar 31, 2018 | $1.00M | Jul 1, 2019 |
| FY2018 | Mar 31, 2017 | $2.99M | Jun 28, 2018 |
| FY2017 | Mar 31, 2016 | $1.94M | Jun 29, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $18.30M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $27.72M | Apr 15, 2025 |
| FY2023 | Mar 31, 2023 | $16.65M | Jul 14, 2023 |
| FY2023 | Mar 31, 2022 | $22.67M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $16.76M | Jul 14, 2022 |
| FY2021 | Mar 31, 2020 | $16.60M | Jul 14, 2021 |
| FY2020 | Mar 31, 2019 | $12.19M | Feb 19, 2021 |
| FY2019 | Mar 31, 2018 | $13.15M | Jul 1, 2019 |
| FY2018 | Mar 31, 2017 | $11.64M | Jun 28, 2018 |
| FY2017 | Mar 31, 2016 | $10.46M | Jun 29, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $28.82M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $20.14M | Apr 15, 2025 |
| FY2023 | Mar 31, 2023 | $6.32M | Jul 14, 2023 |
| FY2023 | Mar 31, 2022 | $12.63M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $8.85M | Jul 14, 2022 |
| FY2021 | Mar 31, 2020 | $10.91M | Jul 14, 2021 |
| FY2020 | Mar 31, 2019 | $3.69M | Feb 19, 2021 |
| FY2019 | Mar 31, 2018 | $5.34M | Jul 1, 2019 |
| FY2018 | Mar 31, 2017 | $4.19M | Jun 28, 2018 |
| FY2017 | Mar 31, 2016 | $4.81M | Jun 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | $10.33M | Jul 14, 2023 |
| FY2023 | Mar 31, 2022 | $10.04M | Jul 14, 2023 |
| FY2023 | Mar 31, 2021 | $7.91M | Jul 14, 2023 |
| FY2022 | Mar 31, 2020 | $5.69M | Jul 14, 2022 |
| FY2021 | Mar 31, 2019 | $8.50M | Jul 14, 2021 |
| FY2020 | Mar 31, 2018 | $7.81M | Feb 19, 2021 |
| FY2019 | Mar 31, 2017 | $7.44M | Jul 1, 2019 |
| FY2018 | Mar 31, 2016 | $5.65M | Jun 28, 2018 |
| FY2017 | Mar 31, 2015 | $3.93M | Jun 29, 2017 |
| FY2017 | Mar 31, 2014 | $3.71M | Jun 29, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (353) | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | (263) | Apr 15, 2025 |
| FY2023 | Mar 31, 2023 | (1) | Jul 14, 2023 |
| FY2023 | Mar 31, 2022 | 0 | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | 1 | Jul 14, 2022 |
| FY2021 | Mar 31, 2020 | 0 | Jul 14, 2021 |
| FY2019 | Mar 31, 2019 | 0 | Jul 1, 2019 |
| FY2019 | Dec 31, 2018 | 0 | Jul 1, 2019 |
| FY2019 | Sep 30, 2018 | 0 | Jul 1, 2019 |
| FY2019 | Jun 30, 2018 | 0 | Jul 1, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (353) | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | (263) | Apr 15, 2025 |
| FY2023 | Mar 31, 2023 | (1) | Jul 14, 2023 |
| FY2023 | Mar 31, 2022 | 0 | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | 1 | Jul 14, 2022 |
| FY2021 | Mar 31, 2020 | 0 | Jul 14, 2021 |
| FY2019 | Mar 31, 2019 | 0 | Jul 1, 2019 |
| FY2019 | Dec 31, 2018 | 0 | Jul 1, 2019 |
| FY2019 | Sep 30, 2018 | 0 | Jul 1, 2019 |
| FY2019 | Jun 30, 2018 | 0 | Jul 1, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | $2.89M | Jul 14, 2023 |
| FY2023 | Mar 31, 2022 | $2.29M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $396.6K | Jul 14, 2022 |
| FY2021 | Mar 31, 2020 | $345.2K | Jul 14, 2021 |
| FY2020 | Mar 31, 2019 | $211.4K | Feb 19, 2021 |
| FY2019 | Mar 31, 2018 | $813.9K | Jul 1, 2019 |
| FY2019 | Mar 31, 2017 | $2.31M | Jul 1, 2019 |
| FY2018 | Mar 31, 2016 | $2.12M | Jun 28, 2018 |
| FY2017 | Mar 31, 2015 | $116.3K | Jun 29, 2017 |
| FY2017 | Mar 31, 2014 | $1.35M | Jun 29, 2017 |